Tag Archive for ‘cancer’
Neoadjuvant and perioperative chemotherapy for localized pancreatic cancer: Leveraging small and large databases in the absence of Level 1 evidence
In the rapidly evolving clinical paradigms for localized pancreatic cancer, a combination of Level 1 data and large and small database studies can inform disease management.
The potential role of NCDB data in treating rare malignancy is explored.
Before adjourning in December, Congress passed two spending bills to keep most health care programs and federal agencies funded through October 1, 2020, with some monies directed specifically to firearm injury and cancer research.
Recommendations from the second volume of Operative Standards for Cancer Surgery are highlighted.
Studying behavioral risk factors are key in planning effective cancer prevention and screening programs.
The OPTI-Surg study evaluates an efficient screening and optimization tool for improving outcomes after major cancer surgery.
This article describes the challenges of obtaining and transporting uncompromised cancer resection specimens.
Strategies for preventing ultraviolet exposure in younger populations are explored.
The inaugural “National Cancer Database (NCDB) cancer bytes” column describes how the database will be used to summarize emerging trends in cancer care.
The second volume of Operative Standards for Cancer Surgery, scheduled to be released in early 2017, describes operations for cancers of the esophagus, stomach, rectum, thyroid, and skin (melanoma).
The Patient-Centered Outcomes Research Institute has awarded three research funding contracts to the ACS Cancer Research Program of the Alliance for Clinical Trials in Oncology with the goal of developing a more patient-centered and individualized approach to post-treatment surveillance of colorectal, breast, and lung cancers.
A brief overview of health care activities at the state level in 2013 followed by a summary of legislative and policy trends for 2014 are highlighted in this article.
The American College of Surgeons Oncology Group (ACOSOG), the Cancer and Leukemia Group B (CALGB), and the North Central Cancer Treatment Group (NCCTG) recently merged to form the Alliance for Clinical Trials in Oncology.